MDB Insider Sales: 8,004 Shares Sold Recently; New Form 144 Filed
Rhea-AI Filing Summary
Form 144 filing by an insider related to MongoDB, Inc. (MDB) discloses a proposed sale of 664 common shares with an aggregate market value of $209,565.04, scheduled approximately for 09/02/2025 on NASDAQ. The shares were originally acquired on 10/01/2009 as a VC investment and paid for in cash. The filing also lists recent 10b5-1 sales on 08/28/2025 totaling 8,004 shares for gross proceeds of $2,400,000 (6,668 shares by Charles M. Hazard Jr. for $2,000,400 and 1,336 shares by The Narragansett Bay Childrens Trust for $400,800). The filer certifies under Rule 144 statements about material nonpublic information and references any applicable 10b5-1 trading plan.
Positive
- Proper regulatory compliance: The filer submitted a Rule 144 notice with acquisition details and 10b5-1 disclosures.
- Transparency on provenance: Acquisition date (10/01/2009) and cash payment are disclosed, clarifying the holding origin.
Negative
- Insider selling activity: Recent 10b5-1 sales on 08/28/2025 totaled 8,004 shares for $2,400,000 in gross proceeds.
Insights
TL;DR: Insider sale notice for a small block of shares; recent 10b5-1 activity shows modest monetization by related parties.
The filing shows a proposed Rule 144 sale of 664 shares valued at about $209.6k and discloses 10b5-1 sales on 08/28/2025 totaling 8,004 shares for $2.4M in gross proceeds. Relative to the 81,356,893 shares outstanding noted in the filing, these transactions represent a de minimis percentage of the float and are unlikely to change company control or capital structure. The inclusion of acquisition details (10/01/2009 VC investment) and the 10b5-1 sales offers transparency on the provenance of shares and timing. For investors, this is routine insider liquidity rather than evidence of company operational change.
TL;DR: Properly filed Rule 144 notice with 10b5-1 disclosures; governance procedures appear followed.
The filer affirms the absence of undisclosed material adverse information and references Rule 10b5-1 trading instructions where applicable. The documentation of acquisition date, payment method, and relation to the issuer aligns with regulatory expectations. The recent 10b5-1 sales by named parties are disclosed with gross proceeds, supporting compliance and transparency. No departures from standard disclosure or governance controls are apparent within this filing's content.
FAQ
What does the Form 144 for MDB disclose about the proposed sale?
When were the securities being sold originally acquired?
Does the filing state whether the seller knows of material nonpublic information?